Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Cancer Research
Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
Prevention Research

Abstract #11: Transcriptional repression of androgen-receptor by cancer chemopreventive D,L-sulforaphane in human prostate cancer cells

Su-Hyeong Kim and Shivendra Singh
Su-Hyeong Kim
University of Pittsburgh Cancer Institute, Pittsburgh, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shivendra Singh
University of Pittsburgh Cancer Institute, Pittsburgh, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published May 2009
  • Article
  • Info & Metrics
Loading
AACR Annual Meeting-- Apr 18-22, 2009; Denver, CO

Abstract

Because prostate cancer continues to be a leading cause of cancer related deaths among men in the United States novel strategies for prevention and treatment of this deadly malignancy are highly desirable. We have shown previously that D,L-sulforaphane (SFN), a synthetic analogue of cruciferous-vegetable derived L-isomer, inhibits growth of cultured human prostate cancer cells regardless of their androgen responsiveness or p53 status. We also found that oral gavage of SFN retards growth of PC-3 human prostate cancer xenografts in athymic mice and prostate cancer progression and pulmonary metastasis in a transgenic mouse model of prostate cancer without causing any harmful side effects. We now demonstrate that SFN treatment causes transcriptional repression of androgen receptor (AR), a ligand-activated transcription factor implicated in normal prostate growth and maintenance and prostate cancer development, in cultured human prostate cancer cells. The SFN treatment decreased protein levels of AR in a concentration- and time-dependent manner in LNCaP (an androgen-dependent cell line) and C4-2 (an androgen-independent variant of LNCaP cells) human prostate cancer cell lines. The SFN-mediated suppression of AR protein level was accompanied by significant decrease in cellular as well as secreted levels of prostate specific antigen, an AR-regulated gene product, in both LNCaP and C4-2 cells. RT-PCR analysis revealed dose-dependent decrease in AR mRNA levels indicating transcriptional repression of AR expression by SFN exposure. The SFN treatment also caused significant decrease in AR promoter activity as judged by luciferase reporter assay. Finally, growth of LNCaP and C4-2 cell stimulated by synthetic androgen R1881 was significantly inhibited in the presence of SFN. In conclusion, the present study demonstrates that SFN treatment causes transcriptional suppression of AR leading to down-regulation of PSA protein levels in human prostate cancer cells. This investigation was supported by the USPHS grants CA115498 and CA101753 awarded by the National Cancer Institute.

Citation Information: In: Proc Am Assoc Cancer Res; 2009 Apr 18-22; Denver, CO. Philadelphia (PA): AACR; 2009. Abstract nr 11.

Footnotes

  • 100th AACR Annual Meeting-- Apr 18-22, 2009; Denver, CO

  • American Association for Cancer Research
Back to top
Cancer Research: 69 (9 Supplement)
May 2009
Volume 69, Issue 9 Supplement
  • Table of Contents
  • Index by Author

Sign up for alerts

Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Abstract #11: Transcriptional repression of androgen-receptor by cancer chemopreventive D,L-sulforaphane in human prostate cancer cells
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
Citation Tools
Abstract #11: Transcriptional repression of androgen-receptor by cancer chemopreventive D,L-sulforaphane in human prostate cancer cells
Su-Hyeong Kim and Shivendra Singh
Cancer Res May 1 2009 (69) (9 Supplement) 11;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Abstract #11: Transcriptional repression of androgen-receptor by cancer chemopreventive D,L-sulforaphane in human prostate cancer cells
Su-Hyeong Kim and Shivendra Singh
Cancer Res May 1 2009 (69) (9 Supplement) 11;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
Advertisement

Related Articles

Cited By...

More in this TOC Section

Prevention Research

  • Abstract LB-153: Lotus leaf and Cassia seed extracts, through activating Nrf2 pathway, suppress TPA-induced mouse skin cell transformation
  • Abstract LB-174: Patient navigation in Appalachia: results from a survey of current practices
  • Abstract LB-167: A novel metabolite of citrus tangeretin epigenetically inhibits the growth of human prostate cancer cells
Show more 3

Biological and Biochemical Mechanisms of Prevention -- Poster Presentations - Proffered Abstracts

  • Abstract #29: Mitochondrial bioenergetics is an apoptogenic regulator for N-(4-hydroxyphenyl)retinamide in premalignant and malignant prostate epithelial cells
  • Abstract #30: Kalopanaxsaponin A reduces human oral squamous cell carcinoma (OSCC) invasion via inhibition of mRNA stability and trafficking of matrix metalloproteinase-9 (MMP-9)
  • Abstract #6: Development of a dual fluorescence reporter system for detecting microsatellite instability in human colorectal cancer cells
Show more 3
  • Home
  • Alerts
  • Feedback
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2018 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement